5th ZAP Cancer Workshop & 4th Training, 23-25 November 2026, Interdisciplinary oncology throughout the patient pathway & Genome Editing: Introduction & Applications, Medical University of Graz, Graz, Austria
Workshop 5: Interdisciplinary oncology throughout the patient pathway
November 23-25, 2026
Location: ZMF Conference Room (ground floor)
Day 1 : Monday, 23 November
| Time | Program |
|---|---|
| 13:30 – 14:00 | Brief introduction to afternoon clinical sessions |
| 14:00 – 15:00 | Introduction to the Biobank Graz and tour of facility Meeting location: ZWT I Seminar Room |
| 15:30 – 16:30 | The molecular diagnostic portfolio and the Molecular Tumor Board Division of Oncology — Leo Edlinger – What is available beyond the diagnostics performed at first diagnosis, and which patients are candidates. – The Molecular Tumor Board: mandate, referral criteria, and how a case moves through it. Selected cases: which diagnostics were ordered, how the results were assessed, and how a recommendation is reached when the evidence base is limited. |
Day 2 : Tuesday, 24 November
| Time | Program |
|---|---|
| 13:45 – 14:30 | Precision oncology in clinical practice Division of Oncology — Prof. Philipp Jost |
| 14:45 – 16:00 | Digital pathology in Graz: hands-on session and scanning facility visit Diagnostic and Research Institute of Pathology — Markus Plass – The slide scanning infrastructure, and how digitized slides move through the routine diagnostic workflow. – Working at the viewing stations with scanned cases from earlier in the afternoon. – Image analysis and AI-supported diagnostic tools currently in use and in development. – Walk-through of the scanning facility. |
Day 3 : Wednesday, 25 November
| Time | Program |
|---|---|
| 13:30 – 14:15 | Liquid biopsy in clinical practice Division of Oncology — Samantha Hasenleithner – When a blood-based test is ordered instead of, or in addition to, tissue. – ESR1 testing as a worked example: the clinical question, the timing of the test, and the treatment decision that follows. – Practical aspects from the ordering clinician’s side: turnaround time, reimbursement, and how to read a negative result. – Where the evidence supports routine use, and where it does not. |
| 14:25 – 15:45 | From “bedside-to bench-and back” Closing roundtable and evaluation Division of Oncology — Michael Dengler |
Training 4 : Genome Editing: Introduction & Applications
November 23-25, 2026
Location: ZMF Conference Room (ground floor)
Day 1 : Monday, 23 November
| Time | Program |
|---|---|
| 9:00 – 9:15 | Welcome Michael Dengler |
| 9:15 – 10:45 | Genome Editing — A Practical Overview Division of Oncology — Michael Dengler |
| 11:00 – 12:00 | Choosing the right tool Division of Oncology — Michael Dengler |
| 12:00 – 13:30 | Lunch |
Day 2 : Tuesday, 24 November
| Time | Program |
|---|---|
| 9:00 – 10:30 | Practical Design & Experimental Planning – CRISPR knockout and CRISPR activation Division of Oncology — Gustav Jonsson |
| 11:00 – 12:30 | Practical Design & Experimental Planning – whole genome CRISPR screens Division of Oncology — Michael Dengler & Amar Balihodzic |
| 12:30 – 13:45 | Lunch |
Day 3 : Wednesday, 25 November
| Time | Program |
|---|---|
| 9:00 – 10:30 | Editing of primary Cancer Cells Division of Oncology — Gustav Jonsson |
| 11:00 – 12:30 | In Vivo Genome Editing & Mouse Models Division of Oncology — Michael Dengler |
| 12:30 – 13:30 | Lunch |